Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000056

Drug Information
NameFoscarnet
SynonymsFoscarnet sodico [Spanish]; Spectrum3_001484; Foscarnetum natricum [Latin]; Spectrum2_000668; Foscarnet sodico; KBio2_001839; 4428-95-9 (Parent); Formic acid, phosphono-; Triapten; 34156-56-4; Foscarnetum natricum [INN-Latin]; Carboxyphosphonic acid; CHEMBL754; Foscarnet sodique [INN-French]; MSL & PFA; Phosphonoformic acid trisodium salt hexahydrate; KBioSS_001839; Foscarnet sodium (USAN/INN); AC1NB82R; KBio2_006975; 63585-09-1; Spectrum_001359; Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, hexahydrate; MolPort-003-895-968; HMS502N17; P6801_SIGMA; Foscarmet; 1nki; CHEBI:60269; dihydroxyphosphanecarboxylic acid oxide; Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody; Dihydroxyphosphinecarboxylic acid oxide trisodium salt hexahydrate; foscarnet; Phosphonoformic acid; FOSCARNET SODIUM; LS-105953; AR-1L5079; AC1L1FVT; NChemBio.2007.9-comp7; 4428-95-9; Phosphinecarboxylic acid, dihydroxy-, oxide; Trisodium phosphonoformate hexahydrate; D02267; SPECTRUM1502019; Sodium phosphonoformate tribasic hexahydrate; Phosphonoformate; trisodium dioxidophosphinecarboxylate oxide; DRG-0017; Foscarnet sodium hydrate (JAN); Phosphonoformic acid, trisodium salt; Forscarnet sodium; Trisodium carboxyphosphate; PFA & rIFN.alpha.A; 63585-09-1 (tri-hydrochloride salt); A-29622; Spectrum4_000840; UNII-964YS0OOG1; CHEBI:141644; Foscarneto sodico [INN-Spanish]; LS-105952; Ambap63585-09-1; Foscarnet & IFN-.ALPHA.; Foscarnet sodique [French]; CID44561; AC-2085; CHEBI:127780; Dihydroxyphosphinecarboxylic acid oxide; KBio1_000915; Dihydroxyphosphinecarboxylic acid oxide trisodium salt; NCGC00094941-02; trisodium phosphonatoformate; CID169569; DB00529; BSPBio_003067; Trisodium phosphonoformte hexahydrate; UNII-364P9RVW4X; sodium dioxidophosphanecarboxylate oxide hydrate(3:1:6); IDI1_000915; SPBio_000735; EHB 776; AC1L5400; CID3415; LS-183979; Foscarnet sodium [USAN:INN:BAN]; Formic acid, phosphono-, trisodium salt, hexahydrate; Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt; Phosphonoformic acid & IFN-.ALPHA.; Foscavir (TN); Foscavir; Phosphonoformic acid, trisodium salt, hexahydrate; A 29622; D00579; MolPort-003-665-560; Phgosphonocarboxylic acid; Foscarnet sodique; P6801_ALDRICH; CHEMBL666; 79510_FLUKA; Spectrum5_000932; DivK1c_000915; phosphonomethanoic acid; HMS1921D18; trisodium carboxyphosphate (anhydrous); Virudin; NCGC00094941-01; trisodium phosphonoformate (anhydrous); Trisodium phosphonoformate; KBio2_004407; trisodium phosphonatoformate hexahydrate; foscarnet sodium hexahydrate; NSC313410; Foscarneto sodico; AC1L2C37; LS-187793; EHB-776; trisodium dioxidophosphanecarboxylate oxide; HS-0008; Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon; Foscarnetum natricum; HMS2092N15; Foscarnet sodium hydrate; LS-187063; NINDS_000915; AC1Q1UNV; KBio3_002567; Prestwick_1024; KBioGR_001419; C06456
Trade NameFoscavir
CompanyAstraZeneca plc
IndicationHerpes viruses
[ICD9: 053, 054   ICD10: B00, B02]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/CH3O5P.3Na.H2O/c2-1(3)7(4,5)6;;;;/h(H,2,3)(H2,4,5,6);;;;1H2/q;
3*+1;/p-3
InChIKeyXKEXMCIFTJJLBI-UHFFFAOYSA-K
Canonical SMILESC(=O)([O-])P(=O)([O-])[O-].O.[Na+].[Na+].[Na+]    
Therapeutic ClassAntiviral Agents
CAS NumberCAS 63585-09-1
FormulaCH3O5P
PubChem Compound IDCID 16218554.
PubChem Substance IDSID 24887462.
SuperDrug ATC IDJ05AD01
SuperDrug CAS ID004428959;
TargetHIV reverse transcriptaseInhibitor[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 077174 To Reference
Ref 2Agents for treating human immunodeficiency virus infection. Am J Hosp Pharm. 1994 Sep 15;51(18):2251-67; quiz 2286-7. To Reference
Ref 3Evaluation of the HIV-1 reverse transcriptase inhibitory properties of extracts from some medicinal plants in Kenya. Afr J Health Sci. 2002 Jan-Jun;9(1-2):81-90. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543